You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphangioleiomyomatosis

Showing 1 - 25 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study of the Disease Process of Lymphangioleiomyomatosis

Recruiting
  • Lung Disease
  • +3 more
  • Toshibia Aquilion One CT
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Lymphangioleiomyomatosis Trial in Milan (Nintedanib)

Completed
  • Lymphangioleiomyomatosis
  • Milan, Italy
    Pneumology unit
Sep 26, 2022

National Lymphangioleiomyomatosis Registry, France

Recruiting
  • Lymphangioleiomyomatosis
    • Lyon, France
      Hôpital Louis Pradel
    Aug 2, 2022

    Lymphangioleiomyomatosis, a Study on Cathepsin K

    Recruiting
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis Complex
    • 24h urine
    • urine sample
    • Tours, France
      University hospital
    Jul 18, 2022

    Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

    Recruiting
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis Complex
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2022

    Lymphangioleiomyomatosis Trial in Spain (Loratadine, Placebo 10mg/day added to rapamycin for 12 months)

    Recruiting
    • Lymphangioleiomyomatosis
    • Loratadine
    • Placebo 10mg/day added to rapamycin for 12 months
    • Hospitalet de Llobregat, Barcelona, Spain
    • +5 more
    Jan 12, 2022

    LAM, Lymphangioleiomyomatosis Trial in United States (Sirolimus)

    Recruiting
    • LAM
    • Lymphangioleiomyomatosis
    • Los Angeles, California
    • +9 more
    Jan 11, 2022

    Arterial Stiffness in Patients With Respiratory Diseases

    Enrolling by invitation
    • Chronic Respiratory Diseases
    • +6 more
    • Breath test using the Compact PTR-TOF-MS
    • +2 more
    • Moscow, Russian Federation
      I.M. Sechenov First Moscow State Medical University (Sechenov Un
    Feb 6, 2023

    Lymphangioleiomyomatosis Trial in Beijing (11C-Choline)

    Not yet recruiting
    • Lymphangioleiomyomatosis
    • Beijing, Dongcheng, China
      Peking union medical college hospital
    Oct 8, 2021

    Lymphangioleiomyomatosis (LAM) Trial in Boston (Celecoxib)

    Completed
    Has Results
    • Lymphangioleiomyomatosis (LAM)
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jan 18, 2022

    Pulmonary Function Trial in Beijing

    Recruiting
    • Pulmonary Function
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Sep 18, 2021

      Lymphangioleiomyomatosis (LAM) Trial in Nashville (Glutamine)

      Completed
      • Lymphangioleiomyomatosis (LAM)
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Aug 10, 2021

      Helicobacter Pylori and Its Toxins in Lung and Digestive System

      Completed
      • Pulmonary Disease
      • +5 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jul 30, 2021

        Lymphatic Malformation, Generalized Lymphatic Anomaly (GLA), Central Conducting Lymphatic Anomaly Trial in Boston

        Recruiting
        • Lymphatic Malformation
        • +9 more
          • Boston, Massachusetts
            Boston Children's Hospital
          Sep 8, 2022

          Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

          Active, not recruiting
          • Hypomelanotic Macules
          • +8 more
            • Tirana, Albania
            • +7 more
            Mar 23, 2022

            Lymphangioleiomyomatosis, Sleep Disorder, Sleep Apnea Syndromes Trial in Bologna (LAM patients underwent PSG)

            Recruiting
            • Lymphangioleiomyomatosis
            • +3 more
            • LAM patients underwent PSG
            • Bologna, Italy
              Azienda Ospedaliero-Universitaria di Bologna
            Mar 17, 2021

            Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

            Recruiting
            • Tuberous Sclerosis
            • Lymphangioleiomyomatosis
            • Phlebotomy
            • +3 more
            • Birmingham, Alabama
            • +22 more
            Jan 6, 2023

            Lymphangioleiomyomatosis Trial in France, Italy, United States (Everolimus)

            Completed
            Has Results
            • Lymphangioleiomyomatosis
            • Boston, Massachusetts
            • +3 more
            Nov 16, 2020

            Safety and Durability of Sirolimus for Treatment of LAM

            Recruiting
            • Lymphangioleiomyomatosis
            • Stanford, California
            • +19 more
            Jan 11, 2022

            Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

            Active, not recruiting
            • Advanced Malignant Neoplasm
            • +38 more
            • Bevacizumab
            • +5 more
            • Houston, Texas
              M D Anderson Cancer Center
            Jul 18, 2022

            Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Philadelphia (Simvastatin, Sirolimus Oral Product, Everolimus Oral

            Completed
            Has Results
            • Lymphangioleiomyomatosis
            • Tuberous Sclerosis Complex
            • Philadelphia, Pennsylvania
              University of Pennsylvania
            Aug 12, 2020

            Pulmonary Lymphangioleiomyomatosis Trial in United States (saracatinib)

            Terminated
            • Pulmonary Lymphangioleiomyomatosis
            • Stanford, California
            • +4 more
            Jul 28, 2020

            Lymphangioleiomyomatosis Trial in New York, Charleston (Imatinib Mesylate 400Mg Capsule, Placebo - Capsule)

            Completed
            Has Results
            • Lymphangioleiomyomatosis
            • Imatinib Mesylate 400Mg Capsule
            • Placebo - Capsule
            • New York, New York
            • +1 more
            Jun 4, 2020

            Benefits of Pulmonary Rehabilitation in Severe

            Completed
            • Lymphangioleiomyomatosis
            • +2 more
            • Pulmonary Rehabilitation
            • Schönau Am Königssee, Germany
              Schoen Klinik Berchtesgadener Land
            Jan 16, 2020

            Lymphatic Disorders Trial in Beijing (68Ga-NEB)

            Recruiting
            • Lymphatic Disorders
            • Beijing, Beijing, China
              Peking Union Medical College Hospital, Chinese Academy of Medica
            Feb 15, 2020